Serological Profiling for Malaria Surveillance Using a Standard ELISA Protocol.

Murungi LM, Kimathi RK, Tuju J, Kamuyu G, Osier FHA. Methods Mol Biol. 2019 Jul 2013:83-90.

​

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.

Kamuyu G, Tuju J, Kimathi R, Mwai K, Mburu J, Kibinge N, Chong Kwan M, Hawkings S, Yaa R, Chepsat E, Njunge JM, Chege T, Guleid F, Rosenkranz M, Kariuki CK, Frank R, Kinyanjui SM, Murungi LM, Bejon P, Färnert A, Tetteh KKA, Beeson JG, Conway DJ, Marsh K, Rayner JC, Osier FHA.  Front Immunol. 2018 Dec 11;9:2866.

​

The 2015-2016 Malaria Epidemic in Northern Uganda; What Are the Implications for Malaria Control Interventions?.

Ogwang R, Akena G, Yeka A, Osier F, Idro R. Acta Trop. 2018 Dec;188:27-33.

​

Vaccine candidate discovery for the next generation of malaria vaccines.

Tuju J, Kamuyu G, Murungi LM, and Osier FHA. Immunology. 2017 Oct;152(2):195-206.

​

Changes in Malaria Epidemiology in Africa and New Challenges for Elimination.

Nkumama IN, O'Meara WP, Osier FH. Trends Parasitol. 2017 Feb;33(2):128-140.

​

Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life.

Murungi LM, Sondén K, Odera D, Oduor LB, Guleid F, Nkumama IN, Otiende M, Kangoye DT, Fegan G, Färnert A, Marsh K, Osier FH. Int J Parasitol. 2017 Feb;47(2-3):153-162.

​

Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.

Murungi LM, Sondén K, Llewellyn D, Rono J, Guleid F, Williams AR, Ogada E, Thairu A, Färnert A, Marsh K, Draper S, Osier FHA. Infect Immun. 2016 Mar 24;84(4):950-963.

​

Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity.

Rono J, Färnert A, Murungi L, Ojal J, Kamuyu G, Guleid F, Nyangweso G, Wambua J, Kitsao B, Olotu A, Marsh K, Osier FH.

BMC Med. 2015 May 13;13:114.

​

New antigens for a multicomponent blood-stage malaria vaccine.

Osier FH, Mackinnon MJ, Crosnier C, Fegan G, Kamuyu G, Wanaguru M, Ogada E, McDade B, Rayner JC, Wright GJ, Marsh K.

Sci Transl Med. 2014 Jul 30;6(247):247ra102.

​

Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.

Osier FH, Feng G, Boyle MJ, Langer C, Zhou J, Richards JS, McCallum FJ, Reiling L, Jaworowski A, Anders RF, Marsh K, Beeson JG. BMC Med. 2014 Jul 1;12:108.

​

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.

Murungi LM, Kamuyu G, Lowe B, Bejon P, Theisen M, Kinyanjui SM, Marsh K, Osier FH. Vaccine. 2013 Aug 20;31(37):3936-42